Back to search

Article

Prevalence of late stage in 507 Medication-related osteonecrosis of the jaws (MRONJ) sites: comparison between cancer and osteometabolic patients

2021-04-12

Abstract excerpt

The present retrospective study we compared 507 sites of MRONJ occurred in 394 patients to highlight possible differences between cancer and non-cancer patients with stage III MRONJ. Five hundred and seven sites of MRONJ were observed between January 2004 and March 2021 at the Center of Oral Medicine and Laser Surgery of the Academic Hospital of University of Parma. Patients were sub-classified in two groups: Gro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f985cdf3-0100-5470-b462-426485321471
DOI
10.32388/9yp1ev.2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prevalence of late stage in 507 Medication-related osteonecrosis of the jaws (MRONJ) sites: comparison between cancer and osteometabolic patientsDOI 10.32388/9yp1ev.2
Denosumab-Related Osteonecrosis of the Jaw: a five year monocentric retrospective study of Ancona General HospitalSemantic proximity
Etiological Study on Changes in Oral Microbial Microenvironment Induced by Anti-Osteoclastic Drugs and Subsequent Development of MRONJSemantic proximity
Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: A retrospective and observational studySemantic proximity
International Expert-Based Consensus Definition, Staging Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Inter-Disciplinary Modified Delphi StudySemantic proximity
Surgical treatment of MRONJ in oncology and non-oncology patients: a retrospective studySemantic proximity
Simplifying the dental/periodontal management of patients with metabolic bone fragility receiving treatment with denosumabSemantic proximity
Genetic Background of Medication-Related Osteonecrosis of the Jaw: Current Evidence and Future Perspectives.Semantic proximity
Difference in outcomes in surgical treatment of stage II-II MRONJ in oncological and non-oncological patients.Semantic proximity
The Trend of Dental Check-Up And Incidence of Dental Complications Following The Use of Bone Modifying Agents In Patients With Metastatic Breast And Prostate Cancer: Analysis of Data From The Korean National Health Insurance ServiceSemantic proximity
SIRT1 Gene SNP rs932658 Is Associated With Medication-Related Osteonecrosis of the Jaw.Semantic proximity
Osteonecrosis of the Jaw in Patients with Clear Cell Renal Cell Carcinoma Treated with Targeted Agents: A Case Series and Large-Scale Pharmacovigilance AnalysisSemantic proximity
Surgical and conservative treatment outcomes of medication-related osteonecrosis of the jaw in relation to tori: A retrospective studySemantic proximity
Select a neighboring publication to make it the new centre.